The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Motivational properties of opioids: evidence that an activation of σ-receptors mediates reinforcement processes
Abstract
The role of central delta-opioid receptors in the mediation of opioid reinforcement and endogenous reward processes was examined using a non-biased place-preference conditioning procedure. Intracerebroventricular (i.c.v.) administration of the selective delta-receptor agonist, [D-Pen2, D-Pen5]-enkephalin (DPDPE, 10.0-25.0 micrograms) produced a significant preference for the drug-associated place and a similar effect was observed following i.c.v. injections of morphine (10.0 micrograms). Administration of the delta-receptor antagonist, ICI 174,864, at doses (1.0-5.0 micrograms, i.c.v.) which had no aversive effects when tested alone, abolished the reinforcing properties of DPDPE. Such treatment did not, however, modify the effect of morphine. These findings demonstrate the involvement delta- as well as mu-receptors in the motivational properties of opioids and suggest that the activation of either receptor type is sufficient for the elicitation of appetitively reinforcing effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Based on animal studies, the role of opioids in the positive reinforcing effects of natural rewards and drugs of abuse has largely been attributed to MOR in the NAC, VP, and VTA, though some part is also played by DOR (van Ree and de Wied 1980; Shippenberg et al 1987; Hubner and Koob 1990; Olmstead and Franklin 1997a; Corrigall et al 2000; Pecina and Berridge 2000; Van Ree et al 2000; Gerrits et”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Shippenberg et al 1987
In the citing paper
“Nonetheless, the three receptor types have different behavioral domains, with MOR and DOR mediating generally positive motivation and affect, while KOR mediates generally negative motivation and aversion (Pfeiffer et al 1986; Shippenberg et al 1987; Pecina and Berridge 2000; McLaughlin et al 2003; for reviews see Van Ree et al 2000; Le Merrer et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Shippenberg et al 1987
Citations
Cites
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,959
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,671
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.
Chang, K. J., & Cuatrecasas, P. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30115-1 · Cited by 683
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 515
Self-citationThe binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties
Magnan, J., Paterson, S. J., Tavani, A., & Kosterlitz, H. W. (1982) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00495865 · Cited by 509
Mucha, R. F., & Iversen, S. D. (1984) · Psychopharmacology · doi:10.1007/bf00427782 · Cited by 311
Self-administration of methionine enkephalin into the nucleus accumbens
Goeders, N. E., Lane, J. D., & Smith, J. E. (1984) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(84)90284-3 · Cited by 245
Experimental methods for the study of state-dependent learning.
Overton, D. A. (1974) · PubMed · Cited by 243
Cited by
Sorted by citations
Items 101–166 of 166
Analgesic, anti-inflammatory, and anti-pyretic activity1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_9 · Cited by 25
Matsuzawa, S., Suzuki, T., Misawa, M., & Nagase, H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01606-6 · Cited by 25
Motivational Effects of Opioids
Shippenberg, T. S. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77540-6_26 · Cited by 25
Self-citationGreenwell, T. N., Zangen, A., Martin‐Schild, S., Wise, R. A., & Zadina, J. E. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10464 · Cited by 24
Walker, B. M. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.01.001 · Cited by 22
Mori, T., Ito, S., Kita, T., Narita, M., Suzuki, T., & Sawaguchi, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.035 · Cited by 23
Endogenous opioid system: a promising target for future smoking cessation medications
Norman, H., & D’Souza, M. S. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4582-0 · Cited by 23
Szumlinski, K. K., Maisonneuve, I. M., & Glick, S. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02069-2 · Cited by 23
Bosse, K. E., Jutkiewicz, E. M., Gnegy, M. E., & Traynor, J. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.017 · Cited by 22
Gonzalez-Nicolini, M. V., Berglind, W. J., Cole, K. S., Keogh, C. L., & McGinty, J. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00488-3 · Cited by 22
Mavridis, M., & Besson, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00043-3 · Cited by 22
Desensitization of δ-opioid receptors in nucleus accumbens during nicotine withdrawal
McCarthy, M. J., Zhang, H., Neff, N. H., & Hadjiconstantinou, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2028-z · Cited by 22
Delay‐Goyet, P., Zajac, J., & Roques, B. P. (1990) · Neurochemistry International · doi:10.1016/0197-0186(90)90112-7 · Cited by 21
Kotlinska, J. H., Gibuła‐Tarłowska, E., Pachuta, A., Kunce, D., Witkowska, E., Chung, N. N., Schiller, P. W., & Izdebski, J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833e7e97 · Cited by 19
Jutkiewicz, E. M., Baladi, M. G., Folk, J. E., Rice, K. C., & Woods, J. H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123844 · Cited by 19
Persson, S., Jónsdóttir, I. H., Thorén, P., Post, C., Nyberg, F., & Hoffmann, P. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90274-7 · Cited by 18
MECHANISMS OF DRUG ADDICTION: FOCUS ON POSITIVE REINFORCING PROPERTIES OF MORPHINE
Kivastik, T. (1996) · DSpace repository (University of Tartu) · Cited by 18
Bardo, M. T., Gehrke, B. J., Shortridge, B. E., & Rauhut, A. S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)01049-3 · Cited by 17
Pertussis toxin attenuates intracranial morphine self-administration
Self, D. W., & Stein, L. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90563-9 · Cited by 17
Martin, T. J., Kim, S. A., Cannon, D. G., Sizemore, G. M., Bian, D., Porreca, F., & Smith, J. E. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39161-x · Cited by 17
Giardino, N. D., Aloyz, R. S., Zollinger, M., Miller, M. W., & DesGroseillers, L. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19961014)374:2 · Cited by 16
Assessment of SNC 80 and Naltrindole Within a Conditioned Taste Aversion Design
Hutchinson, A. C. W., Simpson, G. R., Randall, J. F., Zhang, X., Calderon, S. N., Rice, K. C., & Riley, A. L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00278-1 · Cited by 15
Bosse, K. E., Jutkiewicz, E. M., Schultz‐Kuszak, K., Mabrouk, O. S., Kennedy, R. T., Gnegy, M. E., & Traynor, J. R. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.027 · Cited by 12
Freet, C. S., Wheeler, R. A., Leuenberger, E., Mosblech, N. A. S., & Grigson, P. S. (2013) · Behavioral Neuroscience · doi:10.1037/a0033943 · Cited by 11
Glycyl-l-Glutamine Injected Centrally Suppresses Alcohol Drinking in P Rats
Simpson, C. W., Resch, G. E., Millington, W. R., & Myers, R. D. (1998) · Alcohol · doi:10.1016/s0741-8329(97)00167-5 · Cited by 11
Drug dependence: neuropharmacology and management
Deslandes, P. N., Pache, D. M., & Sewell, R. D. E. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702760088992 · Cited by 11
Motivational Effects of Opioids: Neurochemical and Neuroanatomical Substrates
Shippenberg, T. S., & Bals-Kubik, R. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_20 · Cited by 11
Self-citationCocaine Effects on Dopamine and Opioid Peptide Neural Systems: Implications for Human Cocaine Abuse
Hurd, Y. L. (1996) · PsycEXTRA Dataset · doi:10.1037/e495672006-006 · Cited by 11
Ito, S., Mori, T., & Sawaguchi, T. (2006) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32801155a1 · Cited by 10
Presynaptic Actions of Opioids
Johnson, S. W., & North, R. A. (1993) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4684-6825-0_5 · Cited by 10
Carmo, G. P. D., Mello, N. K., Rice, K. C., Folk, J. E., & Negus, S. S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.075 · Cited by 9
Recent Findings on the Mechanism of Action of Morphine
Valverde, O., Maldonado, R. J., & Kieffer, B. L. (1998) · CNS Drugs · doi:10.2165/00023210-199810010-00001 · Cited by 9
Tyr-W-MIF-1-induced conditioned place preference
Noresa, W. L., Olson, R. D., Olson, G. A., Vaccarino, A. L., Bell, R. L., Zadina, J. E., & Kastin, A. J. (1999) · Peptides · doi:10.1016/s0196-9781(99)00029-7 · Cited by 9
BW373U86: A Non‐Peptidic, Systemically‐Active δ Opioid Agonist
Negus, S. S., & Picker, M. J. (1996) · CNS Drug Reviews · doi:10.1111/j.1527-3458.1996.tb00290.x · Cited by 8
Beloate, L. N., & Coolen, L. M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.008 · Cited by 7
Haaseth, R. C., Zalewska, T., Davis, P., Yamamura, H. I., Porreca, F., & Hruby, V. J. (1997) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1997.tb01182.x · Cited by 7
Cazala, P., & David, V. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90561-f · Cited by 7
Brain sites involved in δ-opioid receptor-mediated actions
Ableitner, A. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90282-8 · Cited by 7
Chronic exposure to antibodies directed against anti-opiate peptides alter δ-opioid receptor levels
Goodman, C. B., Heyliger, S. O., Emilien, B., Partilla, J. S., Yang, H., Lee, C. H., Cadet, J. L., & Rothman, R. B. (1999) · Peptides · doi:10.1016/s0196-9781(99)00151-5 · Cited by 7
Comparative mood states and cognitive skills of cigarette smokers, deprived smokers and nonsmokers
Parrott, A. C., & Garnham, N. J. (1998) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199807)13:5 · Cited by 53
Opioid analgesia: new information from gene knockout studies
Clarke, S., & Kitchen, I. (1999) · Current Opinion in Anaesthesiology · doi:10.1097/00001503-199910000-00020 · Cited by 6
Effects of opioid antagonists on unconditioned and conditioned hyperactivity to morphine
Rauhut, A. S. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00855-9 · Cited by 5
Modification of morphine-induced place preference by diabetes
Kamei, J., Ohsawa, M., Suzuki, T., & Nagase, H. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01302-2 · Cited by 4
Cannabinoid-Opioid Interactions
Miller, M. L., Chadwick, B. J., Morris, C. V., Michaelides, M., & Hurd, Y. L. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_15 · Cited by 3
Molecular Mechanisms of Opioid Dependence by Using Knockout Mice
Kieffer, B. L., & Simonin, F. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_1 · Cited by 3
Opposing Tonically Active Endogenous Opioid System Modulating the Mesolimbic Dopamine Reward Pathway
Herz, A. (1995) · Springer eBooks · doi:10.1007/978-3-7091-6901-8_1 · Cited by 3
Self-citationSánchez, M., & Miquel (2003) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 3
Naloxonazine reveals the role of μ1-opioid receptor in the rewarding effects of morphine
Piepponen, P. T., Kivastik, T., Katajamäki, J., Zharkovsky, A., & Ahtee, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90320-4 · Cited by 3
Endogenous Opioid Systems in the Control of Pain
Millan, M. J., Weihe, E., & Członkowski, A. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_15 · Cited by 3
Neurobiology of opioid use disorder
Cucinello‐Ragland, J. A., Lintz, T., & Morón, J. A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-26504-4.00008-9 · Cited by 2
Molecular Pharmacology and Neuroanatomy
Acquas, E. (2000) · Handbooks of pharmacology and toxicology · doi:10.1201/9781420036961.ch34 · Cited by 2
Behavioral Pharmacology of Opiates
Zacny, J. P., & Walker, E. A. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2913-9_24 · Cited by 2
Drug-Addiction and Drug-Dependency
France, C. P. (2013) · Springer eBooks · doi:10.1007/978-3-642-25240-2_10 · Cited by 2
Modulation of voltage-dependent potassium currents by opiates in facial motoneurons of neonatal rats
Kumazawa, Y., Nishimura, Y., Akamine, T., Lin, M., Asahara, T., Shibuya, H., & Yamamoto, T. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00223-2 · Cited by 2
Gonzalvez, M. L., Vargas, M. L., & Milanés, M. V. (1994) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(94)90251-8 · Cited by 2
Dykstra, L. A. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60963-3_5 · Cited by 2
Biological detectors in liquid chromatography
Idei, M., Pajor, A., Guoth, J., & Menyhárt, J. (1989) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)82783-8 · Cited by 1
Shippenberg, T. S. (1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3_19 · Cited by 1
Self-citationNowicki, J. P., Pratchett, M. S., Walker, S. P. W., Coker, D. J., & O’Connell, L. A. (2017) · King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) · doi:10.1101/214759 · Cited by 1
Effects of chronic nicotine on behavioural and neurochemical responses to morphine
Kivinummi, T. (2009) · Työväentutkimus Vuosikirja
Side Effects of Central Analgesic Drugs
Arendt‐Nielsen, L. (2013) · Springer eBooks · doi:10.1007/978-3-642-25240-2_15
Effect of δ opioid antagonists on the morphine-induced place preference in DDY and CXBK mice
Suzuki, T., Yoshiike, M., Funada, M., Kamei, J., Misawa, M., & Nagase, H. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90233-x
Die Rolle des dopaminergen Belohnungssystems bei der Entwicklung psychischer Abhängigkeit
Herz, A., Shippenberg, T. S., Bals-Kubik, R., & Spanagel, R. (1992) · Springer eBooks · doi:10.1007/978-3-642-77086-9_4
Self-citationSide Effects of Central Analgesic Drugs
France, C. P. (2006) · Springer eBooks · doi:10.1007/3-540-29804-5_10
Bidlack, J. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.97044-2
Metadata
- Authors
- Shippenberg, T. S., Bals-Kubik, R., & Herz, A.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Corresponding author
- Shippenberg, T.S.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 1987-12
- Volume
- 436
- Issue
- 2
- Pages
- 234-239
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2084913220
- Cited by
- 166
- References
- 22
- Citations by year
- 2025: 1 · 2018: 1 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 5
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- delta opioid receptor, opioid reinforcement, place preference, morphine, DPDPE, ICI 174,864, mu-opioid receptor, intracerebroventricular administration
- MeSH terms
- Animals, Appetitive Behavior, Avoidance Learning, Enkephalin, Leucine, Enkephalins, Injections, Intraventricular, Male, Morphine, Motivation, Rats, Inbred Strains, Receptors, Opioid, Reinforcement, Psychology, Receptors, Opioid, delta, Enkephalin, D-Penicillamine (2,5)-, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review